Clinical Trials Logo

Clinical Trial Summary

To investigate safety of Single Doses of BMS-986177 in Patients with End Stage Renal Disease treated with hemodialysis

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT03000673
Study type Interventional
Source Bristol-Myers Squibb
Status Completed
Phase Phase 1/Phase 2
Start date May 23, 2017
Completion date October 23, 2017

See also
  Status Clinical Trial Phase
Recruiting NCT03454854 - Effectiveness of the Application(APP) on Individualized Antithrombotic Therapy N/A